Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$492M |
| 2 |
LLL
L3 Technologies, Inc.
LLL
|
+$392M |
| 3 |
Apple
AAPL
|
+$245M |
| 4 |
AGN
Allergan plc
AGN
|
+$238M |
| 5 |
NXP Semiconductors
NXPI
|
+$226M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$568M |
| 2 |
Coty
COTY
|
+$491M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$224M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$211M |
| 5 |
Sysco
SYY
|
+$208M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.06% |
| 2 | Technology | 11.97% |
| 3 | Financials | 10.69% |
| 4 | Consumer Discretionary | 8.47% |
| 5 | Industrials | 7.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Procter & Gamble
PG
$336B
| $166M | 0.25% |
1,509,909
+588,167
| +64% | +$62.7M |
|
52
Entergy
ETR
$48.8B
| $165M | 0.25% |
3,200,662
+436,726
| +16% | +$21.3M |
|
53
Bio-Rad Laboratories Class A
BIO
$10.2B
| $164M | 0.25% |
525,924
+105,050
| +25% | +$31.5M |
|
|
ETFC
54
DELISTED
E*Trade Financial Corporation
ETFC
| $161M | 0.24% |
3,601,961
+294,221
| +9% | +$14.1M |
|
55
Meta Platforms (Facebook)
META
$1.4T
| $160M | 0.24% |
827,265
-201,696
| -20% | -$36.9M |
|
|
NBL
56
DELISTED
Noble Energy, Inc.
NBL
| $160M | 0.24% |
7,124,013
+5,351,433
| +302% | +$127M |
|
57
S&P Global
SPGI
$127B
| $159M | 0.24% |
696,625
+159,996
| +30% | +$34.9M |
|
58
Honeywell
HON
$68.4B
| $156M | 0.23% |
947,714
-801,576
| -46% | -$128M |
|
59
PUT
Netflix
NFLX
$331B
| $153M | 0.23% |
4,155,000
+1,485,000
| +56% | +$53.6M |
|
60
Zoetis
ZTS
$32.1B
| $153M | 0.23% |
1,344,530
-128,629
| -9% | -$13.5M |
|
61
PUT
iShares Russell 2000 ETF
IWM
$81.9B
| $152M | 0.23% |
978,800
-476,500
| -33% | -$73.5M |
|
62
Gilead Sciences
GILD
$181B
| $149M | 0.22% |
2,208,668
-1,745,720
| -44% | -$115M |
|
63
Regeneron Pharmaceuticals
REGN
$85.9B
| $148M | 0.22% |
473,318
+439,550
| +1,302% | +$146M |
|
64
IQVIA
IQV
$42.8B
| $148M | 0.22% |
916,872
+399,364
| +77% | +$56M |
|
65
CALL
Alphabet (Google) Class A
GOOGL
$4.22T
| $147M | 0.22% |
2,708,000
+1,108,000
| +69% | +$64.1M |
|
66
Kimberly-Clark
KMB
$36.4B
| $145M | 0.22% |
1,088,825
+449,729
| +70% | +$58M |
|
67
D.R. Horton
DHI
$41.5B
| $145M | 0.22% |
3,358,499
+1,321,944
| +65% | +$58.5M |
|
68
Humana
HUM
$45.5B
| $144M | 0.22% |
543,520
+384,300
| +241% | +$97.5M |
|
69
UnitedHealth
UNH
$350B
| $144M | 0.22% |
590,921
+230,140
| +64% | +$55.4M |
|
|
HRC
70
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $144M | 0.22% |
1,372,490
+299,144
| +28% | +$30.3M |
|
71
PUT
State Street SPDR S&P Regional Banking ETF
KRE
$4.5B
| $143M | 0.21% |
2,671,400
+976,800
| +58% | +$52.2M |
|
72
Goldman Sachs
GS
$303B
| $142M | 0.21% |
693,186
+560,071
| +421% | +$111M |
|
|
ARRY
73
DELISTED
Array Biopharma Inc
ARRY
| $140M | 0.21% |
3,021,920
+1,500,142
| +99% | +$42.1M |
|
74
PUT
PayPal
PYPL
$52.7B
| $136M | 0.2% |
1,189,800
+451,300
| +61% | +$50M |
|
75
Dentsply Sirona
XRAY
$2.18B
| $136M | 0.2% |
2,323,390
+1,357,763
| +141% | +$73M |
|
Similar funds
Israel Englander's Q2 2019 Portfolio in Review
As of Q2 2019, Israel Englander held 4,801 positions worth $66.5B, down 0.45% from $66.8B the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.
Israel Englander's Q2 2019 filing shows 865 new, 1,488 increased, 1,571 reduced and 810 closed positions. Its largest new stake was Moody's: 638,271 shares worth $125M. The largest sale was Walt Disney, an estimated $568M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q2 2019 buy was Moody's: 638,271 shares worth $125M.
- Israel Englander added most to LyondellBasell Industries in Q2 2019, an estimated $492M increase.
- Israel Englander's biggest Q2 2019 reduction was Walt Disney, cutting an estimated $568M.
- Israel Englander fully exited Sysco in Q2 2019, selling an estimated $208M.
- Israel Englander's ten largest holdings make up 7.7% of its $66.5B portfolio in Q2 2019.
- Israel Englander opened 865 new positions and closed 810 in Q2 2019.
- Israel Englander's portfolio value fell 0.45% quarter-over-quarter to $66.5B.
Based on Millennium Management's 13F filing for Q2 2019, filed 14 Aug 2019.